Breast cancer is the most common cancer affecting women around the world. Because early detection is closely tied with the chances for survival, researchers are constantly looking for better ways to catch cancer at its earliest stages.
A team of cancer researchers in Israel have created a new screening for breast cancer that’s surprisingly simple and affordable. So far, it’s smelling like a success.
Researchers at Israel’s Ben-Gurion University of the Negev and Soroka University Medical Center in Tel Aviv say they have developed a new and accurate way to screen for early breast cancer, using an electronic nose to analyze breath and a urine test analysis.
In their study, published in Computers in Biology and Medicine, the researchers said the methods they used allowed them to isolate relevant data and thereby more accurately identify breast cancer biomarkers.
The study showed that the researchers managed to detect breast cancer with more than 95 percent average accuracy using two inexpensive commercial electronic noses (e-nose) that identified unique breath patterns in women with breast cancer. In addition, they used gas-chromatography mass spectrometry (GC-MS) to analyze substances found in urine. The statistical analyses of urine samples submitted by both healthy patients and those diagnosed with breast cancer yielded 85 percent average accuracy, they researchers said.